COVID-19's immuno-pathology and cardiovascular diseases
The pandemic of COVID-19 in worldwide causes recent millions of morbidity and mortality in all countries and is the most important challenge in the world in recent years. Coronavirus is a single-stranded RNA virus and infection with COVID-19 leads to acute respiratory distress syndrome, lung inflammation, cytokine storm, and death. The other complications include endothelial dysfunction, activation of coagulation, thromboembolic events, and vascular disease. Cardiovascular complications such as myocardial and stroke ischemia, pulmonary thromboembolism, systemic arterial, and deep vein thrombosis were reported. In this review, we presented immuno-pathological mechanisms and the effects of COVID-19 on the cardiovascular system, heart, vessels, coagulation system, and molecular glance of immuno-inflammation to the COVID-19's pathology on the cardiovascular system.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Journal of investigative medicine : the official publication of the American Federation for Clinical Research - 71(2023), 2 vom: 17. Feb., Seite 71-80 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nasab, Entezar Mehrabi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Blood |
---|
Anmerkungen: |
Date Completed 06.02.2023 Date Revised 13.04.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/10815589221141841 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351582088 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351582088 | ||
003 | DE-627 | ||
005 | 20231226051727.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/10815589221141841 |2 doi | |
028 | 5 | 2 | |a pubmed24n1171.xml |
035 | |a (DE-627)NLM351582088 | ||
035 | |a (NLM)36647329 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nasab, Entezar Mehrabi |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19's immuno-pathology and cardiovascular diseases |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.02.2023 | ||
500 | |a Date Revised 13.04.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The pandemic of COVID-19 in worldwide causes recent millions of morbidity and mortality in all countries and is the most important challenge in the world in recent years. Coronavirus is a single-stranded RNA virus and infection with COVID-19 leads to acute respiratory distress syndrome, lung inflammation, cytokine storm, and death. The other complications include endothelial dysfunction, activation of coagulation, thromboembolic events, and vascular disease. Cardiovascular complications such as myocardial and stroke ischemia, pulmonary thromboembolism, systemic arterial, and deep vein thrombosis were reported. In this review, we presented immuno-pathological mechanisms and the effects of COVID-19 on the cardiovascular system, heart, vessels, coagulation system, and molecular glance of immuno-inflammation to the COVID-19's pathology on the cardiovascular system | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Corona virus | |
650 | 4 | |a blood | |
650 | 4 | |a heart | |
650 | 4 | |a immune system | |
650 | 4 | |a infection | |
700 | 1 | |a Aghajani, Hassan |e verfasserin |4 aut | |
700 | 1 | |a Makoei, Reza Hassanzadeh |e verfasserin |4 aut | |
700 | 1 | |a Athari, Seyyed Shamsadin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of investigative medicine : the official publication of the American Federation for Clinical Research |d 1998 |g 71(2023), 2 vom: 17. Feb., Seite 71-80 |w (DE-627)NLM075137704 |x 1708-8267 |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2023 |g number:2 |g day:17 |g month:02 |g pages:71-80 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/10815589221141841 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2023 |e 2 |b 17 |c 02 |h 71-80 |